RECURRENT MYELODYSPLASTIC SYNDROME
Clinical trials for RECURRENT MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for RECURRENT MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for leukemia relapse after transplant
Disease control CompletedThis study tested a drug called guadecitabine combined with donor white blood cell infusions in 55 adults whose leukemia or MDS came back after a stem cell transplant. The goal was to see if the drug could help the donor cells fight the cancer more effectively. The treatment aims…
Matched conditions: RECURRENT MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:29 UTC
-
New hope for tough MDS cases? small trial tests Triple-Drug attack
Disease control CompletedThis early-phase study tested a new drug combination (navitoclax, venetoclax, and decitabine) in 6 adults with high-risk myelodysplastic syndrome (MDS) that returned or didn't respond to initial treatment. The main goals were to find the safest dose and check for side effects. Th…
Matched conditions: RECURRENT MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 06:16 UTC